Tags : Next-Gen RNS System

NeuroPace Reports Positive Results of Next-Gen RNS System for Refractory

Shots: The results are concluded from 9 years’ study evaluating Next-Gen RNS System in 256 patients at 33 epilepsy centers, lacking adequate response to medications The study demonstrated in 50% (3/4), 90% (1/3) reduction in seizures, median seizure reduction was 75%, six months or longer seizure-free periods 28%, seizure-free periods of one year or longer […]Read More